Chief Medical Officer at resTORbio.
Dr. Mannick is Co-Founder and Chief Medical Officer of resTORbio. Prior to joining resTORbio, Dr. Mannick was Executive Director in the New Indications Discovery Unit of the Novartis Institutes of Biomedical Research where she led the clinical program that targets fundamental pathways regulating the biology of aging as a new approach to treating aging-related diseases. Prior to joining Novartis in 2010, Dr. Mannick was a Medical Director at Genzyme working in multiple therapeutic areas and a faculty member at Harvard Medical School and University of Massachusetts Medical School. Her NIH-sponsored laboratory focused on the role of protein S-nitrosylation in physiology and pathophysiology. Dr. Mannick received her A.B. from Harvard College and her M.D. from Harvard Medical School. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and an Infectious Disease fellowship as part of the Harvard Combined Infectious Disease Program.
Visit website: https://www.restorbio.com/team_post_type/joan-mannick-m-d/
See also: resTORbio - Biopharmaceutical company developing therapeutics for aging-related diseases.
Joan Mannick is also referenced in the following:
Annual Scientific Meeting - Metabolism of Ageing
06-Sep-2021 to 08-Sep-2021
Jointly organised with the Biochemical Society - researcher disciplines include biochemistry, biology and medicine
Extending Human Healthspan and Longevity
Online webinar focused on longevity extension without health related issues organized by The New York Academy of Sciences with Nir Barzilai and Pinchas Cohen as keynote speakers.
Longevity Leaders World Congress 2022
26-Feb-2022 to 27-Feb-2022
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
Longevity Medicine Workshop
Workshop is part of ARDD 2021 conference that brings health care providers involved in longevity, organized by Cassandra Coburn and Evelyne Bischof. (FREE)
11-Oct-2021 to 14-Oct-2021
The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan
Targeting Metabesity 2022
10-Oct-2022 to 13-Oct-2022
The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan
UK SPINE Annual Conference 2020
11-Nov-2020 to 20-Nov-2020
Series of events focussed on research and innovation in geroscience and ageing therapeutics
Joan Mannick News
Tornado, new longevity biotech developing safer and effective mTOR inhibitors
Longevity Technology - 03-Mar-2022
Different flavours of rapalogs targeting different age-related conditionsRead more...
Longevity Leaders' latest report on how longevity is disrupting the world
Longevity Leaders (LSX) - 01-Jan-2020
An interesting collection of interviews and white-papers with industry leadersRead more...
Everyday drugs could give extra years of life
New Scientist - 01-Oct-2014
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.Read more...